Oxford Biomedica Transforms With New Deals, R&D Pipeline, And Manufacturing Facilities
CAR-T and TCR-T Program Deal Signed With Juno
The lentivirus gene delivery company, Oxford Biomedica, is to collaborate with Juno Therapeutics on its CAR-T and TCR-T projects, adding to the UK biotech’s transformation into a debt-free company with a growing in-house product pipeline.
